MedTrace Logo

Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa

NCT05141838 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2021-12-17

No results posted yet for this study

Summary

This retrospective prospective study is aimed at studying the level of vitamin D supply and identifying markers of bone tissue remodeling in order to develop approaches to the prevention of osteopenia and osteoporosis in children with congenital epidermolysis bullosa.

Conditions

  • Bullosa Epidermolysis
  • Vitamin D Deficiency
  • Osteoporosis
  • Osteopenia
  • Phosphorus and Calcium Disorders

Interventions

DRUG

Vitamin D

Adding vitamin D preparations to the therapy in the individual required dosage to correct the deficient state

DIETARY_SUPPLEMENT

Oral nutritional supplement

Adding оral nutritional supplement to the therapy depending on the degree of protein-energy malnutrition

Sponsors & Collaborators

  • National Medical Research Center for Children's Health, Russian Federation

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-21
Primary Completion
2023-01-01
Completion
2023-01-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05141838 on ClinicalTrials.gov